Human immunodeficiency virus type 1 in illicit-drug solutions used intravenously retains infectivity

Journal of Clinical Microbiology

Volumn 43, Issue 4, 2005, Pages 1937-1939

  Bobkov, Aleksei F ^a   Selimova, Ludmila M ^a   Khanina, Tatyana A ^a   Zverev, Sergey Y ^d   Pokrovsky, Vadim V ^b   Weber, Jonathan N ^e   Bobkov, Eugene N ^c   Rylkov, Audrey V ^c  

^a D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^b Federal AIDS Centre   (Russian Federation)

^c AIDS Foundation East West   (Russian Federation)

^d Perm Regional AIDS Centre   (Russian Federation)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; ILLICIT DRUG;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; DILUTION; DRUG USE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PH MEASUREMENT; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS STRAIN;

CELL LINE; DRUG CONTAMINATION; HEROIN; HIV INFECTIONS; HIV-1; HUMANS; METHAMPHETAMINE; PAPAVER; SOLUTIONS; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 16844387287     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.4.1937-1939.2005     Document Type: Article

References (5)

1. Dulbecco, R. 1998. End-point method-measurement of the infectious titer of a viral sample, p. 22-25. In R. Dulbecco and H. S. Ginsberg (ed.). Virology, 2nd ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
2. Pokrovsky, V. V., N. N. Ladnaya, I. G. Savchenko, A. T. Goliusov, M. I. Narkevich, M. S. Bochkova, E. V. Buravtsova, V. V. Kulagin, A. N. Kolesnik, O. F. Momot, and S. R. Saukhat. 1998. Epidemic of HIV-infection in Russia. Epidemiol. Infect. Dis. 5:4-11. (In Russian.)
3. Sattar, S. A., and V. S. Springthorpe. 1991. Survival and disinfectant inactivation of the human immunodeficiency virus: a critical review. Rev. Infect. Dis. 13:430-437.
4. van Bueren, J., R. A. Simpson, P. Jacobs, and B. D. Cookson. 1994. Survival of human immunodeficiency virus in suspension and dried onto surfaces. J. Clin. Microbiol. 32:571-574.
5. Watson, A. I., J. Klaniecki, and C. V. Hanson. 1992. Psoralen/UV inactivation of HIV-1-infected cells for use in cytologic and immunologic procedures. AIDS Res. Hum. Retrovir. 6:503-513.